Prof. Dr. Wolfgang Plischke

Professor Dr Wolfgang Plischke is a member of the Helmholtz Association’s senate for the research field “Health”. He is a member of the supervisory board of Bayer AG, where he also served on the management board until 2014 and was responsible for technology, innovation and sustainability as well as for the Asia-Pacific region. In addition, he took over as head of Bayer HealthCare in 2013.

The biologist, who received his PhD at Hohenheim University, started his career with the Bayer subsidiary Miles Diagnostics. In 1995, he became director of Bayer Yakuhin Ltd. in Japan. In 2000, he then took over the Pharmaceuticals business group, first in North America and, two years later, for the whole of Bayer AG. In this position, he was responsible for the pharmaceuticals market for prescription medicines worldwide. From July 1, 2002 until his appointment to the Bayer management board, he was a member of the Bayer HealthCare Executive Committee and headed the Pharmaceuticals division. As a former board member, he became a member of the board of trustees of the “Bayer Science & Education Foundation”.

Outside the Bayer Group, Plischke was a member of the Fund of the Chemical Industry, and chaired the Voice of German Industry’s (BDI) commission on the “Healthcare Industry”. Furthermore, he was vice-president of the European Chemical Industry Council (CEFIC) and chaired the research and innovation programme of CEFIC.

Since 2019, he chairs the board of directors of the Robert Koch Foundation and also chairs the supervisory board of Evotec AG since 2014. In addition, he is a board member of the Walter-Siegenthaler-Gesellschaft and member of the university council of the University of Hohenheim.

In July 2011, Dr Plischke was appointed honorary professor for industrial chemistry at the Ludwig-Maximilians-Universität München (LMU).

Print Version

Contact